{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:18:25Z","timestamp":1783473505819,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2025-39601-44627"],"award-info":[{"award-number":["2025-39601-44627"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2025-39601-44627"],"award-info":[{"award-number":["2025-39601-44627"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01473-1","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T17:14:13Z","timestamp":1777742053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid nanoparticle-encapsulated DNA vaccine prevented lung consolidation following heterologous influenza A virus challenge in pigs"],"prefix":"10.1038","volume":"11","author":[{"given":"The N.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danh C.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Q.","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassandra","family":"Durazo-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Gauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giao P.","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiep L. X.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"1473_CR1","doi-asserted-by":"crossref","unstructured":"Walia, R. R., Anderson, T. K. & Vincent, A. L. Regional patterns of genetic diversity in swine influenza A viruses in the United States from 2010 to 2016. Influenza Other Respir. Viruses 13, 262\u2013273 (2018).","DOI":"10.1111\/irv.12559"},{"key":"1473_CR2","doi-asserted-by":"crossref","unstructured":"Anderson, T. K. et al. A phylogeny-based global nomenclature system and automated annotation tool for H1 hemagglutinin genes from swine influenza A viruses. mSphere 1, e00275-16 (2016).","DOI":"10.1128\/mSphere.00275-16"},{"key":"1473_CR3","doi-asserted-by":"crossref","unstructured":"Anderson, T. K. et al. Swine influenza A viruses and the tangled relationship with humans. Cold Spring Harb. Perspect. Med. 11, a038737 (2021).","DOI":"10.1101\/cshperspect.a038737"},{"key":"1473_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/vaccines3010022","volume":"3","author":"MR Sandbulte","year":"2015","unstructured":"Sandbulte, M. R., Spickler, A. R., Zaabel, P. K. & Roth, J. A. Optimal use of vaccines for control of influenza A virus in swine. Vaccines 3, 22\u201373 (2015).","journal-title":"Vaccines"},{"key":"1473_CR5","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.vaccine.2010.01.049","volume":"28","author":"AL Vincent","year":"2010","unstructured":"Vincent, A. L. et al. Efficacy of inactivated swine influenza virus vaccines against the 2009 A\/H1N1 influenza virus in pigs. Vaccine 28, 2782\u20132787 (2010).","journal-title":"Vaccine"},{"key":"1473_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.vetmic.2007.07.011","volume":"126","author":"AL Vincent","year":"2008","unstructured":"Vincent, A. L., Lager, K. M., Janke, B. H., Gramer, M. R. & Richt, J. A. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vet. Microbiol. 126, 310\u2013323 (2008).","journal-title":"Vet. Microbiol."},{"key":"1473_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/irv.12189","volume":"7","author":"P Kitikoon","year":"2013","unstructured":"Kitikoon, P. et al. Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v. Influenza Other Respir. Viruses 7, 32\u201341 (2013).","journal-title":"Influenza Other Respir. Viruses"},{"key":"1473_CR8","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/0300985812439724","volume":"49","author":"PC Gauger","year":"2012","unstructured":"Gauger, P. C. et al. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A\/H1N1 influenza virus. Vet. Pathol. 49, 900\u2013912 (2012).","journal-title":"Vet. Pathol."},{"key":"1473_CR9","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.vaccine.2011.01.082","volume":"29","author":"PC Gauger","year":"2011","unstructured":"Gauger, P. C. et al. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 29, 2712\u20132719 (2011).","journal-title":"Vaccine"},{"key":"1473_CR10","first-page":"307","volume":"385","author":"DS Rajao","year":"2014","unstructured":"Rajao, D. S., Anderson, T. K., Gauger, P. C. & Vincent, A. L. Pathogenesis and vaccination of influenza A virus in swine. Curr. Top. Microbiol. Immunol. 385, 307\u2013326 (2014).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"1473_CR11","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1016\/j.vaccine.2018.08.072","volume":"36","author":"CK Souza","year":"2018","unstructured":"Souza, C. K. et al. The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease. Vaccine 36, 6103\u20136110 (2018).","journal-title":"Vaccine"},{"key":"1473_CR12","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1016\/j.vaccine.2014.07.059","volume":"32","author":"DS Rajao","year":"2014","unstructured":"Rajao, D. S., Loving, C. L., Gauger, P. C., Kitikoon, P. & Vincent, A. L. Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs. Vaccine 32, 5170\u20135176 (2014).","journal-title":"Vaccine"},{"key":"1473_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2016.01.015","volume":"491","author":"DS Rajao","year":"2016","unstructured":"Rajao, D. S. et al. Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets. Virology 491, 79\u201388 (2016).","journal-title":"Virology"},{"key":"1473_CR14","doi-asserted-by":"crossref","unstructured":"Khurana, S. et al. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease. Sci. Transl. Med. 5, 200ra114 (2013).","DOI":"10.1126\/scitranslmed.3006366"},{"key":"1473_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.virol.2014.10.003","volume":"471-473","author":"PC Gauger","year":"2014","unstructured":"Gauger, P. C. et al. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease. Virology 471-473, 93\u2013104 (2014).","journal-title":"Virology"},{"key":"1473_CR16","doi-asserted-by":"crossref","unstructured":"Artiaga, B. L. et al. Adjuvant use of the invariant-natural-killer-T-cell agonist alpha-galactosylceramide leads to vaccine-associated enhanced respiratory disease in influenza-vaccinated pigs. Vaccines 12, 1068 (2024).","DOI":"10.3390\/vaccines12091068"},{"key":"1473_CR17","doi-asserted-by":"publisher","first-page":"1322879","DOI":"10.3389\/fimmu.2024.1322879","volume":"15","author":"GM do Nascimento","year":"2024","unstructured":"do Nascimento, G. M., de Oliveira, P. S. B., Butt, S. L. & Diel, D. G. Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus. Front. Immunol. 15, 1322879 (2024).","journal-title":"Front. Immunol."},{"key":"1473_CR18","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1128\/CVI.00315-12","volume":"19","author":"DR Braucher","year":"2012","unstructured":"Braucher, D. R. et al. Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs. Clin. Vaccin. Immunol. 19, 1722\u20131729 (2012).","journal-title":"Clin. Vaccin. Immunol."},{"key":"1473_CR19","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1128\/JVI.01038-13","volume":"87","author":"CL Loving","year":"2013","unstructured":"Loving, C. L. et al. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v. J. Virol. 87, 9895\u20139903 (2013).","journal-title":"J. Virol."},{"key":"1473_CR20","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1016\/j.vaccine.2022.07.042","volume":"40","author":"M Wymore Brand","year":"2022","unstructured":"Wymore Brand, M. et al. Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease. Vaccine 40, 5569\u20135578 (2022).","journal-title":"Vaccine"},{"key":"1473_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/1040638720907918","volume":"32","author":"A Sharma","year":"2020","unstructured":"Sharma, A. et al. Detection of live attenuated influenza vaccine virus and evidence of reassortment in the U.S. swine population. J. Vet. Diagn. Invest. 32, 301\u2013311 (2020).","journal-title":"J. Vet. Diagn. Invest."},{"key":"1473_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/mic.0.049601-0","volume":"159","author":"M Saxena","year":"2013","unstructured":"Saxena, M., Van, T. T. H., Baird, F. J., Coloe, P. J. & Smooker, P. M. Pre-existing immunity against vaccine vectors-friend or foe? Microbiology 159, 1\u201311 (2013).","journal-title":"Microbiology"},{"key":"1473_CR23","doi-asserted-by":"crossref","unstructured":"Nguyen, T. N. et al. A single-dose intramuscular immunization of pigs with lipid nanoparticle DNA vaccines based on the hemagglutinin antigen confers complete protection against challenge infection with the homologous influenza virus strain. Vaccines 11, 1596 (2023).","DOI":"10.3390\/vaccines11101596"},{"key":"1473_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00283-24","volume":"9","author":"TN Nguyen","year":"2024","unstructured":"Nguyen, T. N. et al. Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza viruses. mSphere 9, e0028324 (2024).","journal-title":"mSphere"},{"key":"1473_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1155552","volume":"14","author":"J Waldock","year":"2023","unstructured":"Waldock, J. et al. Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: a FLUCOP collaborative study. Front. Immunol. 14, 1155552 (2023).","journal-title":"Front. Immunol."},{"key":"1473_CR26","doi-asserted-by":"publisher","first-page":"e1004757","DOI":"10.1371\/journal.ppat.1004757","volume":"11","author":"CJ Knudson","year":"2015","unstructured":"Knudson, C. J., Hartwig, S. M., Meyerholz, D. K. & Varga, S. M. RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets. PLoS Pathog. 11, e1004757 (2015).","journal-title":"PLoS Pathog."},{"key":"1473_CR27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.autrev.2009.12.006","volume":"9","author":"D Gomez-Martin","year":"2010","unstructured":"Gomez-Martin, D., Diaz-Zamudio, M., Galindo-Campos, M. & Alcocer-Varela, J. Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. Autoimmun. Rev. 9, 454\u2013458 (2010).","journal-title":"Autoimmun. Rev."},{"key":"1473_CR28","doi-asserted-by":"publisher","first-page":"E879","DOI":"10.1073\/pnas.1109797109","volume":"109","author":"M Yu","year":"2012","unstructured":"Yu, M. et al. Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc. Natl. Acad. Sci. USA 109, E879\u2013E888 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1473_CR29","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/sj.onc.1206126","volume":"22","author":"S Baumann","year":"2003","unstructured":"Baumann, S. et al. An unexpected role for FosB in activation-induced cell death of T cells. Oncogene 22, 1333\u20131339 (2003).","journal-title":"Oncogene"},{"key":"1473_CR30","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1172\/JCI45444","volume":"121","author":"X Liao","year":"2011","unstructured":"Liao, X. et al. Kr\u00fcppel-like factor 4 regulates macrophage polarization. J. Clin. Investig. 121, 2736\u20132749 (2011).","journal-title":"J. Clin. Investig."},{"key":"1473_CR31","doi-asserted-by":"publisher","first-page":"eadc9346","DOI":"10.1126\/sciadv.adc9346","volume":"8","author":"J Nah","year":"2022","unstructured":"Nah, J. & Seong, R. H. Kr\u00fcppel-like factor 4 regulates the cytolytic effector function of exhausted CD8 T cells. Sci. Adv. 8, eadc9346 (2022).","journal-title":"Sci. Adv."},{"key":"1473_CR32","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus, A. & Ghosh, S. The NF-\u03baB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1, a000034 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1473_CR33","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41590-020-0765-7","volume":"21","author":"C Tan","year":"2020","unstructured":"Tan, C. et al. NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting. Nat. Immunol. 21, 1267\u20131279 (2020).","journal-title":"Nat. Immunol."},{"key":"1473_CR34","first-page":"1","volume":"71","author":"H Kim","year":"2017","unstructured":"Kim, H. The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages. Sci. Rep. 71, 1\u201315 (2017).","journal-title":"Sci. Rep."},{"key":"1473_CR35","doi-asserted-by":"publisher","first-page":"19140","DOI":"10.1074\/jbc.M802513200","volume":"283","author":"G Droga-Mazovec","year":"2008","unstructured":"Droga-Mazovec, G. et al. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J. Biol. Chem. 283, 19140\u201319150 (2008).","journal-title":"J. Biol. Chem."},{"key":"1473_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biochi.2020.04.009","volume":"174","author":"DD Zhdanov","year":"2020","unstructured":"Zhdanov, D. D. et al. Inhibition of nuclease activity by a splice-switching oligonucleotide targeting deoxyribonuclease 1 mRNA prevents apoptosis progression and prolong viability of normal human CD4+ T-lymphocytes. Biochimie 174, 34\u201343 (2020).","journal-title":"Biochimie"},{"key":"1473_CR37","doi-asserted-by":"publisher","first-page":"11108","DOI":"10.1074\/jbc.M115.645333","volume":"290","author":"T Li","year":"2015","unstructured":"Li, T. et al. DDIT3 and KAT2A proteins regulate TNFRSF10A and TNFRSF10B expression in endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells. J. Biol. Chem. 290, 11108\u201311118 (2015).","journal-title":"J. Biol. Chem."},{"key":"1473_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.theriogenology.2012.11.017","volume":"79","author":"Y Yang","year":"2013","unstructured":"Yang, Y. et al. Luman recruiting factor regulates endoplasmic reticulum stress in mouse ovarian granulosa cell apoptosis. Theriogenology 79, 633\u2013639.e633 (2013).","journal-title":"Theriogenology"},{"key":"1473_CR39","doi-asserted-by":"publisher","first-page":"e1002230","DOI":"10.1371\/journal.ppat.1002230","volume":"7","author":"JD Brien","year":"2011","unstructured":"Brien, J. D. et al. Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8+ T cell immune responses against West Nile virus infection. PLoS Pathog. 7, e1002230 (2011).","journal-title":"PLoS Pathog."},{"key":"1473_CR40","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.4049\/jimmunol.2300355","volume":"212","author":"C Nguyen","year":"2024","unstructured":"Nguyen, C. et al. Bhlhe40 promotes CD4+ T helper 1 cell and suppresses T follicular helper cell differentiation during viral infection. J. Immunol. 212, 1829\u20131842 (2024).","journal-title":"J. Immunol."},{"key":"1473_CR41","doi-asserted-by":"publisher","first-page":"153259","DOI":"10.1016\/j.prp.2020.153259","volume":"216","author":"N Taefehshokr","year":"2020","unstructured":"Taefehshokr, N., Miao, T., Symonds, A. L., Wang, P. & Li, S. Egr2 regulation in T cells is mediated through IFN\u03b3\/STAT1 and IL-6\/STAT3 signalling pathway. Pathol. Res. Pract. 216, 153259 (2020).","journal-title":"Pathol. Res. Pract."},{"key":"1473_CR42","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.tcb.2004.09.016","volume":"14","author":"FJ Pixley","year":"2004","unstructured":"Pixley, F. J. & Stanley, E. R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14, 628\u2013638 (2004).","journal-title":"Trends Cell Biol."},{"key":"1473_CR43","doi-asserted-by":"publisher","first-page":"e1011476","DOI":"10.1371\/journal.ppat.1011476","volume":"19","author":"A Markin","year":"2023","unstructured":"Markin, A. et al. Reverse-zoonoses of 2009 H1N1 pandemic influenza A viruses and evolution in United States swine results in viruses with zoonotic potential. PLoS Pathog. 19, e1011476 (2023).","journal-title":"PLoS Pathog."},{"key":"1473_CR44","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.1921186117","volume":"117","author":"H Sun","year":"2020","unstructured":"Sun, H. et al. Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection. Proc. Natl. Acad. Sci. USA 117, 17204\u201317210 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1473_CR45","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. The expression kinetics and immunogenicity of lipid nanoparticles delivering plasmid DNA and mRNA in mice. Vaccines 11,1580 (2023).","DOI":"10.3390\/vaccines11101580"},{"key":"1473_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.146.1.201","volume":"146","author":"SB Halstead","year":"1977","unstructured":"Halstead, S. B. & O\u2019Rourke, E. J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med 146, 201\u2013217 (1977).","journal-title":"J. Exp. Med"},{"key":"1473_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","volume":"20","author":"S Bournazos","year":"2020","unstructured":"Bournazos, S., Gupta, A. & Ravetch, J. V. The role of IgG Fc receptors in antibody-dependent enhancement. Nat. Rev. Immunol. 20, 633\u2013643 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1473_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fimmu.2015.00079","volume":"6","author":"LT Vogelpoel","year":"2015","unstructured":"Vogelpoel, L. T., Baeten, D. L., de Jong, E. C. & den Dunnen, J. Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity. Front. Immunol. 6, 79 (2015).","journal-title":"Front. Immunol."},{"key":"1473_CR49","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm918","volume":"9","author":"FP Polack","year":"2003","unstructured":"Polack, F. P., Hoffman, S. J., Crujeiras, G. & Griffin, D. E. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat. Med. 9, 1209\u20131213 (2003).","journal-title":"Nat. Med."},{"key":"1473_CR50","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","volume":"89","author":"HW Kim","year":"1969","unstructured":"Kim, H. W. et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89, 422\u2013434 (1969).","journal-title":"Am. J. Epidemiol."},{"key":"1473_CR51","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/jama.1967.03130250057008","volume":"202","author":"VA Fulginiti","year":"1967","unstructured":"Fulginiti, V. A., Eller, J. J., Downie, A. W. & Kempe, C. H. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 202, 1075\u20131080 (1967).","journal-title":"JAMA"},{"key":"1473_CR52","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","volume":"35","author":"SB Halstead","year":"2017","unstructured":"Halstead, S. B. Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine 35, 6355\u20136358 (2017).","journal-title":"Vaccine"},{"key":"1473_CR53","doi-asserted-by":"publisher","first-page":"9831","DOI":"10.1128\/JVI.77.18.9831-9844.2003","volume":"77","author":"LM Haynes","year":"2003","unstructured":"Haynes, L. M., Jones, L. P., Barskey, A., Anderson, L. J. & Tripp, R. A. Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P. J. Virol. 77, 9831\u20139844 (2003).","journal-title":"J. Virol."},{"key":"1473_CR54","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/030098589503200606","volume":"32","author":"P Halbur","year":"1995","unstructured":"Halbur, P. et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet. Pathol. 32, 648\u2013660 (1995).","journal-title":"Vet. Pathol."},{"key":"1473_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2021.101709","volume":"79","author":"T Oh","year":"2021","unstructured":"Oh, T. et al. Age-related viral load and severity of systemic pathological lesions in acute naturally occurring African swine fever virus genotype II infections. Comp. Immunol. Microbiol. Infect. Dis. 79, 101709 (2021).","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"1473_CR56","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/978-1-0716-0346-8_23","volume":"2123","author":"PC Gauger","year":"2020","unstructured":"Gauger, P. C. & Vincent, A. L. Serum virus neutralization assay for detection and quantitation of serum neutralizing antibodies to influenza A virus in swine. Methods Mol. Biol. 2123, 321\u2013333 (2020).","journal-title":"Methods Mol. Biol."},{"key":"1473_CR57","doi-asserted-by":"publisher","first-page":"108451","DOI":"10.1016\/j.vetmic.2019.108451","volume":"239","author":"H Sun","year":"2019","unstructured":"Sun, H., Sur, J. H., Sillman, S., Steffen, D. & Vu, H. L. X. Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine. Vet. Microbiol. 239, 108451 (2019).","journal-title":"Vet. Microbiol."},{"key":"1473_CR58","first-page":"43","volume":"Chapter 2.E","author":"WHO.","year":"2011","unstructured":"WHO. Manual for the laboratory diagnosis and virological surveillance of influenza. World Health Organ. Chapter 2.E, 43\u201357 (2011).","journal-title":"World Health Organ."},{"key":"1473_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/978-1-4939-0758-8_25","volume":"1161","author":"PC Gauger","year":"2014","unstructured":"Gauger, P. C., Loving, C. L. & Vincent, A. L. Enzyme-linked immunosorbent assay for detection of serum or mucosal isotype-specific IgG and IgA whole-virus antibody to influenza A virus in swine. Methods Mol. Biol. 1161, 303\u2013312 (2014).","journal-title":"Methods Mol. Biol."},{"key":"1473_CR60","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1473_CR61","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nprot.2013.092","volume":"8","author":"H Mi","year":"2013","unstructured":"Mi, H., Muruganujan, A., Casagrande, J. T. & Thomas, P. D. Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8, 1551\u20131566 (2013).","journal-title":"Nat. Protoc."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01473-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01473-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01473-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:03:42Z","timestamp":1783472622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01473-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1473"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01473-1","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.L.X.V., T.N.N., and S.S. are inventors on a pending international patent application entitled \u201cMethods and compositions for vaccine development and delivery\u201d (PCT Application No. PCT\/US2024\/033830; published as WO2024254461A3). Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}